The antiviral drug Paxlovid may not be particularly helpful for patients who are not at high risk for severe COVID-19. However, although the rate of hospitalization and death from any cause was low overall, the group that received Paxlovid had a reduced rate compared with people in the placebo group, according to the researchers. The time from onset to relief of COVID-19 symptoms did not differ significantly between the two study groups. The median time to sustained alleviation of symptoms was 12 days for the Paxlovid group compared with 13 days in the placebo group.
The antiviral drug Paxlovid may not be particularly helpful for patients who are not at high risk for severe COVID-19 . However, although the rate of hospitalization and death from any cause was low overall, the group that received Paxlovid had a reduced rate compared with people in the placebo group, according to the researchers. The time from onset to relief of COVID-19 symptoms did not differ significantly between the two study groups.
The median time to sustained alleviation of symptoms was 12 days for the Paxlovid group compared with 13 days in the placebo group
Antiviral Drug Paxlovid COVID-19 Low-Risk Patients Hospitalization Death Symptoms
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The disconnect between COVID-19 patients and PaxlovidEvangelical minister Eddie Hyatt believes in the healing power of prayer but 'also the medical approach.' So on a Februa
Read more »
Covid patients who could benefit from paxlovid still aren’t getting itDuring the pandemic, the federal government offered Americans a 5-day course of Paxlovid, the antiviral drug that lessens COVID-19 symptoms. But now that Pfizer is charging for it, confusion over insurance coverage, price, has made patients wary.
Read more »
High cost, bureaucracy keeping Paxlovid from COVID patientsSticker shock over the COVID medication has stunned thousands of sick Americans since late December, as Pfizer shifted to commercial sales of Paxlovid. Before...
Read more »
Private Varda Space capsule returns to Earth with space-grown antiviral drug aboardMichael Wall is a Senior Space Writer with Space.com and joined the team in 2010. He primarily covers exoplanets, spaceflight and military space, but has been known to dabble in the space art beat. His book about the search for alien life, 'Out There,' was published on Nov. 13, 2018.
Read more »
Four years since national COVID-19 emergency: The enduring battle with long COVIDIt has officially been four years to the day since the Trump administration declared a national emergency for COVID-19.Nearly 1.2 million Americans lost their l
Read more »
Four years since national COVID-19 emergency: The enduring battle with long COVIDIt has officially been four years to the day since the Trump administration declared a national emergency for COVID-19.Nearly 1.2 million Americans lost their l
Read more »